Breaking News Instant updates and real-time market news.

STAF

Staffing 360 Solutions

$0.92 /

+0.0203 (+2.25%)

08:48
01/22/20
01/22
08:48
01/22/20
08:48

Staffing 360 Solutions says 2020 'shaping up to be a highly productive year'

Staffing 360 Solutions provided its 2020 outlook and previewed fiscal 2019 revenue results. The company said, "2020 Overview: On a macro level, there is growing optimism in the business media that the world economy will continue on a strong path in 2020. We operate in both the US and the UK and those economies are strong. Staffing Industry Analysts recently said that the worst of the temp slowdown may be behind us. Brexit should commence the end of this month, allowing for more certainty about the UK economic outlook. From a corporate perspective, we are still experiencing very strong demand for candidates in each of our business streams and we are making solid progress adding new clients. Cross-sales within the US and within the UK continue to build on recent successes. All four US & UK brands successfully collaborated on a new US-based project late in Q4. We see these new inter-country cross-sales opportunities growing as well. Our fourth quarter engagement of R.W. Baird is active as they assist us with strategic acquisitions - and the related refinancing of our balance sheet to accommodate any successful transaction. That work progresses simultaneously down two paths. First combined acquisition and refinance and second for standalone debt refinance. UK Professional: Clement May - continuing to build upon January 2019 three-year extension with client British American Tobacco, with placements both inside and outside the US. CBSbutler - permanent placements off to a healthy start, that pipeline is strong. Contract placements up in December. Seeing new demand in pharmaceutical and aviation markets. JM Group - growing contract placements for Information Security. US Professional: firstPRO - strong 2019 finish for contract placements with headcount still increasing; permanent placement also increasing. Actively targeting and producing higher level contract placements to increase margins; anticipate increased performance. Lighthouse - strong permanent outlook. Seeing aggressive growth with pharma; on track to become approved vendor for east coast hospital. Anticipate cross-sales success with Commercial this year. US Commercial: Monroe - large accounts performing well with high customer satisfaction rating; win rates have tripled; program for improved account retention; solid opportunities in pipeline. Net Promotor Score measuring customer loyalty is 75+%.

STAF Staffing 360 Solutions
$0.92 /

+0.0203 (+2.25%)

02/08/19
Staffing 360 Solutions raises $4M in a public offering

TODAY'S FREE FLY STORIES

Upgrade
Oil Search upgraded to Overweight from Neutral at JPMorgan » 04:48
02/25/20
02/25
04:48
02/25/20
04:48
OISHY

Oil Search

$0.00 /

+ (+0.00%)

JPMorgan analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Alumina upgraded to Neutral from Underweight at JPMorgan » 04:47
02/25/20
02/25
04:47
02/25/20
04:47
AWCMY

Alumina

$0.00 /

+ (+0.00%)

JPMorgan analyst Lyndon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Engie SA downgraded to Hold from Buy at Deutsche Bank » 04:44
02/25/20
02/25
04:44
02/25/20
04:44
ENGIY

Engie SA

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: USD-CAD has ebbed back below 1.3300 » 04:00
02/25/20
02/25
04:00
02/25/20
04:00

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Update: Markets have have found a more even keel » 03:20
02/25/20
02/25
03:20
02/25/20
03:20

FX Update: Markets have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Morgan Stanley consumer analysts to hold an analyst/industry conference call » 02:30
02/25/20
02/25
02:30
02/25/20
02:30
YUMC

Yum China

$44.11 /

-1.76 (-3.84%)

Consumer Analysts, along…

Consumer Analysts, along with Yum China management, discuss how restaurants are combating the Coronavirus on an Analyst/Industry conference call to be held on February 25 at 4 am.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Asian Market Update: » 02:00
02/25/20
02/25
02:00
02/25/20
02:00

Asian Market Update:…

Asian Market Update: 10-year Treasury yields are up 3.0 bp at 1.401%, as stock market losses started to abate during the Asian session. JGBs rallied and Nikkei and Topix both lost -3.3% in catch up trade after returning from yesterday's holiday's but hopes of additional stimulus measures helped to put a floor under most other markets. The ASX underperformed and dropped -1.0% as growth forecasts for Q1 are being revised down, with a contraction now judged to be increasingly likely. Australian weekly consumer confidence plunged to 108.3 from 109.1. Still reports that U.S. President Trump asked Congress for USD 2.5 B to fight the coronavirus and hopes of stimulus measures elsewhere could help to put a floor under stocks following yesterday's plunge that saw the Dow loosing more than 1000 points. The Hang Seng is currently up 0.15%, CSI 300 and Shanghai Comp still down -0.30% and -0.60% respectively, but the Kospi recovered 1.2% following yesterday's plunge and U.S. futures are up 0.9-1.3%. In forex markets the yen has lost some of its safe haven premium and USD-JPY lifted to 110.84. The front end WTI future meanwhile lifted to USD 51.82 per barrel.

General news
Fed's Mester said virus developments pose a risk, » 01:40
02/25/20
02/25
01:40
02/25/20
01:40

Fed's Mester said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
SS&C price target raised to $61 from $58 at Jefferies » 20:40
02/24/20
02/24
20:40
02/24/20
20:40
SSNC

SS&C

$62.15 /

-1.88 (-2.94%)

Jefferies analyst…

Jefferies analyst Surinder Thind raised his price target on SS&C to $61, adjusting his model to reflect the expected flow-through from the company's Q4 earnings beat and higher operating margins. The analyst also continues to expect SS&C organic growth rate to be about 3% and expects margins to continue improving, but keeps his Hold rating on the stock.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
NextEra Energy initiated with a Sell at Vertical Research » 20:27
02/24/20
02/24
20:27
02/24/20
20:27
NEE

NextEra Energy

$273.96 /

-3.72 (-1.34%)

Vertical Research analyst…

Vertical Research analyst Jonathan Arnold initiated coverage of NextEra Energy with a Sell rating and $62 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Chicken Soup for the Soul initiated with a Buy at DA Davidson » 20:24
02/24/20
02/24
20:24
02/24/20
20:24
CSSE

Chicken Soup for the Soul

$9.25 /

+0.34 (+3.82%)

DA Davidson analyst Tom…

DA Davidson analyst Tom Forte initiated coverage of Chicken Soup for the Soul with a Buy rating and $26 price target. The analyst believes that the company is well positioned to "exploit" the OTT video consumption trend, operating one of the "premier advertising-based-video-on-demand services, Crackle". Forte is positive on the ability of Chicken Soup for the Soul to offer quality video content with minimal capital outlays.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Halliburton awarded digital transformation contract in Indonesia » 20:21
02/24/20
02/24
20:21
02/24/20
20:21
HAL

Halliburton

$19.83 /

-1.43 (-6.73%)

Halliburton announced…

Halliburton announced that Pertamina, the largest Indonesian oil and gas company, deployed all of their petro-technical applications on the iEnergy cloud, a hybrid cloud offering from Landmark, a Halliburton business line, which manages operators' E&P applications. The iEnergy cloud helps reduce corporate infrastructure costs and improve the effectiveness and efficiency of integrating, managing and supporting well data across the company's units and subsidiaries. The multiyear contract will deploy capabilities including artificial intelligence, machine learning and data analytics to solve upstream challenges and support Pertamina's digital transformation initiatives. DecisionSpace 365 applications will enable the company to streamline their workflows across exploration and production, improve drilling performance, enhance decision-making and increase production.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
AB InBev downgraded to Reduce from Buy at HSBC » 20:14
02/24/20
02/24
20:14
02/24/20
20:14
BUD

AB InBev

$69.36 /

-2.24 (-3.13%)

HSBC analyst Carlos Laboy…

HSBC analyst Carlos Laboy downgraded AB InBev to Reduce from Buy with a EUR 60 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Nvidia downgraded to Reduce from Neutral at Nomura Instinet » 20:13
02/24/20
02/24
20:13
02/24/20
20:13
NVDA

Nvidia

$273.26 /

-20.92 (-7.11%)

Nomura Instinet analyst…

Nomura Instinet analyst David Wong downgraded Nvidia to Reduce from Neutral with a $230 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Expedia to cut 3K jobs this week, Bloomberg reports » 20:04
02/24/20
02/24
20:04
02/24/20
20:04
EXPE

Expedia

$112.30 /

-7.83 (-6.52%)

Expedia will cut about 3K…

Expedia will cut about 3K jobs this week as part of its plan to simplify a "bloated" organization, Bloomberg's Olivia Carville writes, cites the company's spokesperson. The report notes that the cuts are not related to the potential impact of the coronavirus but rather reflect the uncertainty around its profit outlook.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Tupperware Brands down 17.5% after below-consensus FY19, FY20 outlook  19:47
02/24/20
02/24
19:47
02/24/20
19:47
TUP

Tupperware Brands

$5.72 /

-0.245 (-4.11%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Tupperware Brands guides FY20 revenue $1.58B-$1.62B, conssensus $1.67B » 19:32
02/24/20
02/24
19:32
02/24/20
19:32
TUP

Tupperware Brands

$5.72 /

-0.245 (-4.11%)

Tupperware Brands states:…

Tupperware Brands states: "The company will only be providing full-year guidance going forward. Based on current business trends and foreign currency rates, the company's full-year fiscal 2020 outlook is provided below. The first half of 2020 reflects similar sales trends as 2019, together with continued investments to drive savings. The second half of 2020 reflects better sales trends supported by go-to-market work in Brazil, China and U.S. & Canada along with the majority of the $50 million cost savings efforts."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Tupperware Brands sees FY19 adj. EPS $1.35-$1.70, consensus $2.78 » 19:30
02/24/20
02/24
19:30
02/24/20
19:30
TUP

Tupperware Brands

$5.72 /

-0.245 (-4.11%)

Sees FY19 revenue…

Sees FY19 revenue "in line with previously provided outlook ranges of down 12% to 14% as reported and down 8% to 10% in local currency", consensus $1.80B. The company states: "The company increased its valuation allowances for deferred tax assets related to foreign tax credits and disallowed interest deductions due to the company's multi-year declining domestic performance resulting in an elevated GAAP tax rate of 84% to 100% and operating tax rate of 55% to 66% for fiscal 2019. The company experienced continued execution challenges and unfavorable macro-economic trends most notably in its core markets of Brazil, China, and U.S. & Canada. The impact on segment profit is expected to be approximately $83 million or $0.75 cents per share, excluding Fuller Mexico of $19-21 million. The company is conducting an investigation primarily into the accounting for accounts payable and accrued liabilities at its Fuller Mexico beauty business to determine the extent to which these matters may further impact results and to assess and enhance the effectiveness of internal controls at this business. This matter is $9-11 million of the total expected $19-21 million full-year impact on an adjusted* pre-tax basis. In addition, total impairments for Fuller Mexico are expected to be approximately $31 million. The total pre-tax impact for 2019 is approximately $50-52 million."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Tesla downgraded to Hold from Buy at Jefferies » 19:28
02/24/20
02/24
19:28
02/24/20
19:28
TSLA

Tesla

$833.82 /

-66.82 (-7.42%)

Jefferies analyst…

Jefferies analyst Philippe Houchois downgraded Tesla to Hold from Buy with a price target of $800, up from $600. The analyst notes that he remains convinced by Tesla's "equity opportunity", but also believes that its valuation needs to be grounded on its potential market size and profitability. Houchois adds that his neutral stance is warranted pending better visibility of the upcoming battery business model, even though he continues to see Tesla as "uniquely engaged in a positive sum-game" within the electric vehicle transition.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
JPMorgan intends to unveil climate initiatives on Tuesday, Reuters reports » 19:22
02/24/20
02/24
19:22
02/24/20
19:22
JPM

JPMorgan

$132.16 /

-3.65 (-2.69%)

JPMorgan intends to…

JPMorgan intends to announce new climate-change initiatives on Tuesday, including limits on financing coal mining and Arctic drilling, as well as a $200B target to provide financing for sustainable projects, Reuters' Elizabeth Dilts Marshall reports. The bank said that it would detail the initiatives at its investor day, the author notes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
BlueLinx says Bluefin Acquisitions offer 'not legitimate' » 19:18
02/24/20
02/24
19:18
02/24/20
19:18
BXC

BlueLinx

$15.50 /

+0.18 (+1.17%)

The company states:…

The company states: "BlueLinx responded further to the recent misleading public statements by an investment firm that goes by the name of Bluefin Acquisitions, LLC. regarding its purported tender offer. In two recent press releases, Bluefin Acquisitions claimed that it was making, and then confirming, a tender offer to acquire at least 35% of the Company's common stock at a price of $24.50 per share, and that Morrow Sodali LLC had been engaged as its information agent. Bluefin Acquisitions went on to claim that it would, in connection therewith, file related tender offer materials with the U.S. Securities and Exchange Commission no later than today, Monday, February 24, 2020. However, no tender offer materials have been filed with the SEC. In addition, the company understands that Morrow Sodali has terminated its engagement with Bluefin Acquisitions and is no longer serving as information agent in connection with the purported offer. The company does not believe that this purported offer is, or was, legitimate or credible. Moreover, the company believes that the purported offeror's actions may be unlawful, and false and misleading in violation of the U.S. securities laws, because they failed to comply with the filing and disclosure requirements under those laws. We once again urge public investors to approach any further communications from the purported offeror with caution, and to rely only on tender offer materials that are properly filed with the SEC."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Apergy sees Q1 revenue $255M-$265M, consensus $268.47M » 19:10
02/24/20
02/24
19:10
02/24/20
19:10
APY

Apergy

$23.15 /

-1.63 (-6.58%)

Sees Q1 adj. EBITDA…

Sees Q1 adj. EBITDA $50M-$56M. Sees FY20 infrastructure related capex at 2.5% of revenue plus Capital expenditure portion for leased ESP investment of $5M-$10M.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Apergy reports Q4 adj. EPS 13c, consensus 14c » 19:08
02/24/20
02/24
19:08
02/24/20
19:08
APY

Apergy

$23.15 /

-1.63 (-6.58%)

Reports Q4 revenue…

Reports Q4 revenue $247.7M, consensus $256.85M. CEO Sivasankaran Somasundaram says: "Since the beginning of the new year, we have seen business activity levels sequentially improve, driven by reloaded North American E&P capital budgets, continued international growth, as well as increased orders by our drill bit customers. Consolidated January 2020 revenue was 11% greater than December 2019 revenue with particular strength in Drilling Technologies, which increased 29%. Additionally, we remain focused on managing our costs, including building on our restructuring savings implemented to date, as well as driving free cash flow generation. Consistent with historical performance, for Apergy, we expect to deliver a free cash flow to revenue ratio of approximately 10% for full year 2020. While the near-term market remains volatile due to global events, we remain focused on the factors under our control. Looking ahead, our merger with ChampionX is expected to close by the end of the second quarter. We are pleased that ChampionX performed as we expected in 2019. Our integration planning is well underway, and as we make progress on our integration planning we are even more excited about our future as a combined company, and we have increased confidence in achieving our target of $75 million in annual cost synergies."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Perrigo, Catalent announce FDA approval of Generic Version of ProAir HFA » 19:01
02/24/20
02/24
19:01
02/24/20
19:01
PRGO

Perrigo

$59.20 /

-0.63 (-1.05%)

, CTLT

Catalent

$56.03 /

-2.94 (-4.99%)

Perrigo (PRGO) and its…

Perrigo (PRGO) and its partner, Catalent Pharma Solutions (CTLT) announced that the FDA has approved Perrigo's abbreviated new drug application for generic albuterol sulfate inhalation aerosol, the first AB-rated generic version of ProAir HFA. Perrigo is launching a limited quantity of generic albuterol sulfate inhalation aerosol and, in collaboration with its development and manufacturing partner Catalent, is ramping up production to meet future demand. Generic albuterol sulfate inhalation aerosol is indicated in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. ProAir HFA gross sales for the previous 12 months were approximately $1.4 billion, as measured by IQVIA.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Deluxe CEO: We're far more than check printing » 18:57
02/24/20
02/24
18:57
02/24/20
18:57
DLX

Deluxe

$38.57 /

-0.61 (-1.56%)

In an interview on…

In an interview on CNBC's Mad Money, Deluxe CEO Barry McCarthy said, "We are an exciting transformation story. We're far more than check printing. Less than 40% of our revenue and volume comes from checks." McCarthy noted the company has "a trusted brand" that gives it a huge advantage over its peers.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.